{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:35:51Z","timestamp":1769754951311,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["surgopensci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery Open Science"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.sopen.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T12:01:33Z","timestamp":1670846493000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Is palpable DCIS more aggressive than screen-detected DCIS?"],"prefix":"10.1016","volume":"11","author":[{"given":"Nina","family":"Balac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Tungate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi R.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Sener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirstyn E.","family":"Brownson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sopen.2022.12.002_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.sopen.2022.12.002_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-013-2670-3","article-title":"Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study","volume":"141","author":"Sprague","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.sopen.2022.12.002_bb0015","author":"Society"},{"issue":"20","key":"10.1016\/j.sopen.2022.12.002_bb0020","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/jnci\/djt256","article-title":"Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?","volume":"105","author":"Punglia","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.sopen.2022.12.002_bb0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","article-title":"Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program","volume":"160","author":"Ernster","year":"2000","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.sopen.2022.12.002_bb0035","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1245\/s10434-011-1707-2","article-title":"Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death","volume":"18","author":"Roses","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.sopen.2022.12.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a diagnosis of ductal carcinoma in situ with death from breast cancer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.sopen.2022.12.002_bb0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clbc.2013.08.002","article-title":"Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up","volume":"13","author":"Sundara Rajan","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"22","key":"10.1016\/j.sopen.2022.12.002_bb0050","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","article-title":"Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy","volume":"95","author":"Kerlikowske","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.sopen.2022.12.002_bb0055","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/cncr.10539","article-title":"Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania","volume":"94","author":"Schwartz","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-013-2598-7","article-title":"Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status","volume":"139","author":"Rauch","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.sopen.2022.12.002_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiology.217.2.r00nv08466","article-title":"Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?","volume":"217","author":"Lee","year":"2000","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.sopen.2022.12.002_bb0070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/M13-2548","article-title":"Prioritization of research addressing management strategies for ductal carcinoma in situ","volume":"160","author":"Gierisch","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.sopen.2022.12.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130077","article-title":"Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression","volume":"34","author":"Carraro","year":"2014","journal-title":"Biosci Rep"},{"issue":"4","key":"10.1016\/j.sopen.2022.12.002_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.sopen.2022.12.002_bb0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s12282-015-0636-5","article-title":"Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management","volume":"23","author":"Sato","year":"2016","journal-title":"Breast Cancer"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejso.2013.12.013","article-title":"The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast","volume":"40","author":"Barnes","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","article-title":"Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases","volume":"98","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.sopen.2022.12.002_bb0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/RLU.0000000000000985","article-title":"Sentinel lymph node biopsy in breast cancer: indications, contraindications, and controversies","volume":"41","author":"Manca","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.sopen.2022.12.002_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejso.2017.10.215","article-title":"Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: a comprehensive review of current data","volume":"44","author":"Charalampoudis","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.soc.2017.01.013","article-title":"Updates in the treatment of breast cancer with radiotherapy","volume":"26","author":"Castaneda","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"10.1016\/j.sopen.2022.12.002_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.amjsurg.2006.06.028","article-title":"What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?","volume":"192","author":"Mabry","year":"2006","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.sopen.2022.12.002_bb0120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1055-9965.EPI-18-0976","article-title":"Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses","volume":"28","author":"Visser","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/A:1021853302033","article-title":"A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer","volume":"77","author":"Rakovitch","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.sopen.2022.12.002_bb0130","author":"NCCN Guidelines Version 3"},{"issue":"7","key":"10.1016\/j.sopen.2022.12.002_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ctrv.2010.03.007","article-title":"Current perspectives of treatment of ductal carcinoma in situ","volume":"36","author":"Estevez","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.sopen.2022.12.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"}],"container-title":["Surgery Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589845022000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589845022000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:22:54Z","timestamp":1762903374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589845022000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"alternative-id":["S2589845022000793"],"URL":"https:\/\/doi.org\/10.1016\/j.sopen.2022.12.002","relation":{},"ISSN":["2589-8450"],"issn-type":[{"value":"2589-8450","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is palpable DCIS more aggressive than screen-detected DCIS?","name":"articletitle","label":"Article Title"},{"value":"Surgery Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sopen.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}